Treatment of acute lymphoblastic leukemia in a second remission

Donald Pinkel, F. Leonard Johnson, E. Donnall Thomas, A. John Barrett, Brad H. Pollock, George R Buchanan

Research output: Contribution to journalLetter

4 Citations (Scopus)

Abstract

To the Editor: Barrett et al. (Nov. 10 issue)1conclude that for children with acute lymphoblastic leukemia (ALL) in a second remission, bone marrow transplants from HLA-identical siblings result in fewer relapses and longer leukemia-free survival than does chemotherapy. This conclusion was based on a comparison of children whose cases were reported to the International Bone Marrow Transplant Registry and children treated with chemotherapy by the Pediatric Oncology Group. Their report arouses some concern. The comparison does not take into account possible differences between the two groups with respect to race or ethnic background, financial and nutritional status, and type. . .

Original languageEnglish (US)
Pages (from-to)823-824
Number of pages2
JournalNew England Journal of Medicine
Volume332
Issue number12
DOIs
StatePublished - Mar 23 1995

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Bone Marrow
Transplants
Drug Therapy
Nutritional Status
Registries
Siblings
Leukemia
Therapeutics
Pediatrics
Recurrence
Survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pinkel, D., Johnson, F. L., Thomas, E. D., Barrett, A. J., Pollock, B. H., & Buchanan, G. R. (1995). Treatment of acute lymphoblastic leukemia in a second remission. New England Journal of Medicine, 332(12), 823-824. https://doi.org/10.1056/NEJM199503233321217

Treatment of acute lymphoblastic leukemia in a second remission. / Pinkel, Donald; Johnson, F. Leonard; Thomas, E. Donnall; Barrett, A. John; Pollock, Brad H.; Buchanan, George R.

In: New England Journal of Medicine, Vol. 332, No. 12, 23.03.1995, p. 823-824.

Research output: Contribution to journalLetter

Pinkel, D, Johnson, FL, Thomas, ED, Barrett, AJ, Pollock, BH & Buchanan, GR 1995, 'Treatment of acute lymphoblastic leukemia in a second remission', New England Journal of Medicine, vol. 332, no. 12, pp. 823-824. https://doi.org/10.1056/NEJM199503233321217
Pinkel, Donald ; Johnson, F. Leonard ; Thomas, E. Donnall ; Barrett, A. John ; Pollock, Brad H. ; Buchanan, George R. / Treatment of acute lymphoblastic leukemia in a second remission. In: New England Journal of Medicine. 1995 ; Vol. 332, No. 12. pp. 823-824.
@article{d6401a9e04db45f8834fd4dc02685930,
title = "Treatment of acute lymphoblastic leukemia in a second remission",
abstract = "To the Editor: Barrett et al. (Nov. 10 issue)1conclude that for children with acute lymphoblastic leukemia (ALL) in a second remission, bone marrow transplants from HLA-identical siblings result in fewer relapses and longer leukemia-free survival than does chemotherapy. This conclusion was based on a comparison of children whose cases were reported to the International Bone Marrow Transplant Registry and children treated with chemotherapy by the Pediatric Oncology Group. Their report arouses some concern. The comparison does not take into account possible differences between the two groups with respect to race or ethnic background, financial and nutritional status, and type.{\^A} .{\^A} .",
author = "Donald Pinkel and Johnson, {F. Leonard} and Thomas, {E. Donnall} and Barrett, {A. John} and Pollock, {Brad H.} and Buchanan, {George R}",
year = "1995",
month = "3",
day = "23",
doi = "10.1056/NEJM199503233321217",
language = "English (US)",
volume = "332",
pages = "823--824",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "12",

}

TY - JOUR

T1 - Treatment of acute lymphoblastic leukemia in a second remission

AU - Pinkel, Donald

AU - Johnson, F. Leonard

AU - Thomas, E. Donnall

AU - Barrett, A. John

AU - Pollock, Brad H.

AU - Buchanan, George R

PY - 1995/3/23

Y1 - 1995/3/23

N2 - To the Editor: Barrett et al. (Nov. 10 issue)1conclude that for children with acute lymphoblastic leukemia (ALL) in a second remission, bone marrow transplants from HLA-identical siblings result in fewer relapses and longer leukemia-free survival than does chemotherapy. This conclusion was based on a comparison of children whose cases were reported to the International Bone Marrow Transplant Registry and children treated with chemotherapy by the Pediatric Oncology Group. Their report arouses some concern. The comparison does not take into account possible differences between the two groups with respect to race or ethnic background, financial and nutritional status, and type. . .

AB - To the Editor: Barrett et al. (Nov. 10 issue)1conclude that for children with acute lymphoblastic leukemia (ALL) in a second remission, bone marrow transplants from HLA-identical siblings result in fewer relapses and longer leukemia-free survival than does chemotherapy. This conclusion was based on a comparison of children whose cases were reported to the International Bone Marrow Transplant Registry and children treated with chemotherapy by the Pediatric Oncology Group. Their report arouses some concern. The comparison does not take into account possible differences between the two groups with respect to race or ethnic background, financial and nutritional status, and type. . .

UR - http://www.scopus.com/inward/record.url?scp=0029650786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029650786&partnerID=8YFLogxK

U2 - 10.1056/NEJM199503233321217

DO - 10.1056/NEJM199503233321217

M3 - Letter

C2 - 7862194

AN - SCOPUS:0029650786

VL - 332

SP - 823

EP - 824

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 12

ER -